Science Explorer Interactive view Map
Company · Brussels · Belgium

Boehringer Ingelheim (Belgium)

Research works
23
▼ 13% vs 2013–17
Citations
535
23.0 per fractional work
Top-10% rate
9.5%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Boehringer Ingelheim (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.30× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.91× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 10.49× its world share, 1 worksImmunology and Micro…Chemistry: 3.67× its world share, 0 worksChemistryComputer Science: 0.15× its world share, 0 worksComputer ScienceHealth Professions: 0.44× its world share, 0 worksHealth ProfessionsMedicine: 3.32× its world share, 4 worksMedicineVeterinary: 74.86× its world share, 1 worksVeterinaryDecision Sciences: 1.19× its world share, 0 worksDecision Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Veterinary, 74.9×. Every wedge is a field page.

Which keywords describe research at Boehringer Ingelheim (Belgium)?

By fractional works in all years, weighted toward what it does more of than the world: Fibrosis, Clinical Trials, Epithelial-Mesenchymal Transition, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, TGF-ß, Treatment and Regeneration.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Epidemiology3▲ 2.7×14 topics
  2. Fibrosis2▲ 55×4 topics
  3. Clinical Trials2▲ 16×4 topics
  4. Epithelial-Mesenchymal Transition2▲ 104×3 topics
  5. Idiopathic Pulmonary Fibrosis2▲ 220×1 topic
  6. Interstitial Lung Disease2▲ 161×2 topics
  7. TGF-ß2▲ 50×1 topic
  8. Treatment2▲ 6.1×10 topics
  9. Regeneration2▲ 39×4 topics
  10. Diagnosis2▲ 6.2×11 topics
  11. Chemotherapy1▲ 7.7×5 topics
  12. Treatment Guidelines1▲ 27×2 topics
  13. Inflammation1▲ 2.1×8 topics
  14. Regenerative Medicine1▲ 25×2 topics
  15. Targeted Therapy1▲ 24×2 topics
  16. ALK Inhibitors1▲ 84×1 topic
  17. EGFR Mutations1▲ 84×1 topic
  18. Nanoparticles1▲ 3.5×2 topics
  19. Patient Safety1▲ 40×2 topics
  20. Translational Research1▲ 135×2 topics
  21. Breast Cancer1▲ 15×2 topics
  22. Inhaler Devices1▲ 147×1 topic
  23. Mesenchymal Stem Cells1▲ 37×2 topics
  24. Pulmonary Drug Delivery1▲ 147×1 topic
  25. Regulatory Challenges1▲ 55×1 topic
  26. Stem Cell Regulation1▲ 187×1 topic
  27. Vaccine Development1▲ 14×3 topics

Which research topics does Boehringer Ingelheim (Belgium) publish most on?

By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory viral infections research, Mesenchymal stem cell research and Tendon Structure and Treatment.

  1. 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  2. 2 Respiratory viral infections research Epidemiology 0 works
  3. 3 Mesenchymal stem cell research Genetics 0 works
  4. 4 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
  5. 5 Immune responses and vaccinations Immunology 0 works
  6. 6 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  7. 7 Veterinary Equine Medical Research Equine 0 works
  8. 8 Pneumonia and Respiratory Infections Epidemiology 0 works
  9. 9 Veterinary Orthopedics and Neurology Small Animals 0 works
  10. 10 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.3%not open62.7%

World: 28% of research is openly available.

with international co-authors63.1%domestic only36.9%

World: 19% is written across borders.

How has Boehringer Ingelheim (Belgium)'s research output changed?

Output in 2018–2022 was 13% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Brussels

All research institutions in Brussels

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.